</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
CB Partner Webinar VDI LABORATORY {{webinarspromoemail3::client_only_logo}} {{webinarspromoemail3::client_only_logo_self_hosted}} {{webinarspromoemail3::client_only_logo_alt}} {{webinarspromoemail3::client_only_logo_width}} {{webinarspromoemail3::client_only_logo_custom_css}} {{webinarspromoemail3::client_color}} {{webinarspromoemail3::client_color_darker}} Biomarkers:{br}Practical Application{br}in Cancer Screening true 1 Credit Hour {{webinarspromoemail3::on_demand}} December 8, 2022 at 8:00 PM {{webinarspromoemail3::remove_webinar_date_and_time_1}} ET 1{nbs}HR Learn How the Latest in Cancer Technology Could Change the Way You{nbs}Practice SAVE YOUR SEAT https://event.on24.com/wcc/r/4022749/E6DE1050FBEB9A6866F03C7DEFBCE970 {{webinarspromoemail3::header_background_image_none}} https://cdn.brief.vet/Clients/VDI/120822_Webinar_Partner_VDI_CustomHeader_600x450%401x.jpg https://cdn.brief.vet/Clients/VDI/120822_Webinar_Partner_VDI_CustomHeader_600x450%402x.jpg {{webinarspromoemail3::header_background_image_1}} {{webinarspromoemail3::header_background_image_2}} {{webinarspromoemail3::header_background_image_3}} {{webinarspromoemail3::header_background_image_4}} {{webinarspromoemail3::header_background_image_5}} {{webinarspromoemail3::header_background_image_6}} {{webinarspromoemail3::supported_by}} {{webinarspromoemail3::client_logo}} https://cdn.brief.vet/Clients/VDI/120822_Webinar_Partner_VDI_Artboard-46%402x.jpg 56 {{webinarspromoemail3::client_logo_alt}} {{webinarspromoemail3::client_logo_url}} {{webinarspromoemail3::place_logos_below_content}} true {{webinarspromoemail3::speaker_image_1}} https://cdn.brief.vet/Clients/VDI/120822_Webinar_Partner_VDI_Email_Speaker_Selting%402x.jpg Kim Selting DVM, DACVIM (Oncology), DACVR (Radiation Oncology) {{webinarspromoemail3::speaker_image_2}} {{webinarspromoemail3::speaker_image_self_hosted_2}} {{webinarspromoemail3::speaker_name_2}} {{webinarspromoemail3::speaker_title_2}} {{webinarspromoemail3::speaker_image_3}} {{webinarspromoemail3::speaker_image_self_hosted_3}} {{webinarspromoemail3::speaker_name_3}} {{webinarspromoemail3::speaker_title_3}} {{webinarspromoemail3::speaker_image_4}} {{webinarspromoemail3::speaker_image_self_hosted_4}} {{webinarspromoemail3::speaker_name_4}} {{webinarspromoemail3::speaker_title_4}} {{webinarspromoemail3::speaker_image_5}} {{webinarspromoemail3::speaker_image_self_hosted_5}} {{webinarspromoemail3::speaker_name_5}} {{webinarspromoemail3::speaker_title_5}} {{webinarspromoemail3::speaker_image_6}} {{webinarspromoemail3::speaker_image_self_hosted_6}} {{webinarspromoemail3::speaker_name_6}} {{webinarspromoemail3::speaker_title_6}} true {{webinarspromoemail3::place_speakers_below_content}} Biomarker detection can provide diagnostic and prognostic utility when it comes to cancer detection and therapy. But do the protocols and recommendations for testing have you confused? Join us for a webinar as we sort through what you need to know to harness the power of this technology for your patients. {{webinarspromoemail3::inside_the_webinar_2}} {{webinarspromoemail3::inside_the_webinar_3}} Biomarkers are substances derived from bodily fluids that reflect the state of health or disease in an individual. When used in combination with physical and other clinicopathologic findings, biomarkers can guide therapy or additional diagnostic testing. Thymidine kinase 1 (TK1) is a soluble marker of proliferation that can be easily measured in the blood and reflect an occult or suspected diagnosis of cancer. Combining 2 or more biomarkers is usually more powerful than considering only the changes in a single biomarker. {{webinarspromoemail3::what_youll_learn_5}} {{webinarspromoemail3::what_youll_learn_6}} Let biomarkers tell you{br}what no other technology can. SAVE YOUR SPOT This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{abs}approval.
Biomarkers: Practical Application in Cancer Screening
Produced by Clinician's Brief & VDI LABORATORY
RACE approved (1 Credit Hour)(1 Credit Hour)
RACE approved (1 Credit Hour)(1 Credit Hour)
Biomarkers:{br}Practical Application{br}in Cancer Screening
Learn How the Latest in Cancer Technology Could Change the Way You{nbs}Practice
Dec  8, 2022
08:00 PM ET (1{nbs}HR)
SAVE YOUR SEAT
SAVE YOUR SEAT
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}{{webinarspromoemail3::client_logo_alt}}
 
Speaker
Kim Selting
DVM, DACVIM (Oncology), DACVR (Radiation Oncology)
Inside the Webinar
Inside the Webinar
Biomarker detection can provide diagnostic and prognostic utility when it comes to cancer detection and therapy. But do the protocols and recommendations for testing have you confused? Join us for a webinar as we sort through what you need to know to harness the power of this technology for your patients.
What you'll learn
  • Biomarkers are substances derived from bodily fluids that reflect the state of health or disease in an individual.
  • When used in combination with physical and other clinicopathologic findings, biomarkers can guide therapy or additional diagnostic testing.
  • Thymidine kinase 1 (TK1) is a soluble marker of proliferation that can be easily measured in the blood and reflect an occult or suspected diagnosis of cancer.
  • Combining 2 or more biomarkers is usually more powerful than considering only the changes in a single biomarker.
Let biomarkers tell you{br}what no other technology can.
SAVE YOUR SPOT
Let biomarkers tell you{br}what no other technology can.
SAVE YOUR SPOT
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{abs}approval.
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{abs}approval.
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}{{webinarspromoemail3::client_logo_alt}}
 
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
Biomarkers: Practical Application in Cancer Screening
Produced by Clinician's Brief & VDI LABORATORY
RACE approved (1 Credit Hour)(1 Credit Hour)
RACE approved (1 Credit Hour)(1 Credit Hour)
Biomarkers:{br}Practical Application{br}in Cancer Screening
Learn How the Latest in Cancer Technology Could Change the Way You{nbs}Practice
Dec  8, 2022
08:00 PM ET (1{nbs}HR)
SAVE YOUR SEAT
SAVE YOUR SEAT
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}{{webinarspromoemail3::client_logo_alt}}
 
Speaker
Kim Selting
DVM, DACVIM (Oncology), DACVR (Radiation Oncology)
Inside the Webinar
Inside the Webinar
Biomarker detection can provide diagnostic and prognostic utility when it comes to cancer detection and therapy. But do the protocols and recommendations for testing have you confused? Join us for a webinar as we sort through what you need to know to harness the power of this technology for your patients.
What you'll learn
  • Biomarkers are substances derived from bodily fluids that reflect the state of health or disease in an individual.
  • When used in combination with physical and other clinicopathologic findings, biomarkers can guide therapy or additional diagnostic testing.
  • Thymidine kinase 1 (TK1) is a soluble marker of proliferation that can be easily measured in the blood and reflect an occult or suspected diagnosis of cancer.
  • Combining 2 or more biomarkers is usually more powerful than considering only the changes in a single biomarker.
Let biomarkers tell you{br}what no other technology can.
SAVE YOUR SPOT
Let biomarkers tell you{br}what no other technology can.
SAVE YOUR SPOT
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{abs}approval.
This program is approved for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{abs}approval.
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail3::client_logo_alt}}{{webinarspromoemail3::client_logo_alt}}